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Postmortem Long QT Syndrome Genetic
Testing for Sudden Unexplained Death in the Young
David J. Tester, BS,* Michael J. Ackerman, MD, PHD*†‡
Rochester, Minnesota
Objectives This study sought to determine the spectrum and prevalence of long QT syndrome (LQTS)-associated mutations
in a large cohort of autopsy-negative sudden unexplained death (SUD).
Background Potentially heritable arrhythmia syndromes may explain a significant proportion of SUD in the young. Here, com-
prehensive postmortem LQTS genetic testing was performed in a cohort of SUD cases.
Methods From September 1998 to March 2004, 49 cases of SUD (30 male patients, average age at death 14.2  10.9
years) were referred by medical examiners/coroners to Mayo Clinic’s Sudden Death Genomics Laboratory. Using
polymerase chain reaction, denaturing high-performance liquid chromatography, and direct DNA sequencing,
open reading frame/splice site mutational analysis was conducted for all 8 genes implicated in the pathogene-
sis of either LQTS (LQT1 to LQT6) or multisystem disorders involving either QT or QU prolongation.
Results Ten LQTS-associated mutations (4 novel) were discovered in 10 SUD cases (20%, 8 female patients, average
age at death 18.0  11.8 years). The LQTS susceptibility mutations LQT1 (5), LQT2 (3), and LQT3 (2) were far
more common among women (8 of 18, 44%) than men (2 of 30, 6.7%, p  0.008). The activities at the time of
SUD included sleep (5), exertion (2), auditory arousal (1), and undetermined (2). Sudden death was the sentinel
event in two-thirds of the cases.
Conclusions In this cardiac channel-focused molecular autopsy investigation of SUD, over one-third of decedents har-
bored a putative cardiac channel mutation: 7 previously reported to host mutations in the RyR2-encoded
calcium release channel and now 10 with LQTS susceptibility mutations. Accordingly, postmortem cardiac
channel genetic testing should be pursued in the evaluation of autopsy-negative SUD. (J Am Coll Cardiol
2007;49:240–6) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.10.010b
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In developed countries, sudden cardiac death is
one of the most common causes of death. In
the U.S., for example, an estimated 1,000
individuals die suddenly each day, with the vast
majority of deaths occurring in the elderly and
most often secondary to coronary artery disease.
udden death in the young is relatively uncommon, with an
ncidence between 1 and 5 per 100,000 patient-years, and
early one-half occur without warning, thus precipitating
he need for a detailed medicolegal investigation, including
utopsy (1). A postmortem analysis may detect a noncardiac
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Department of Medicine, Division of Cardiovascular Diseases, and ‡Department of
ediatric and Adolescent Medicine, Division of Pediatric Cardiology, Mayo Clinic
ollege of Medicine, Rochester, Minnesota. Dr. Ackerman is a consultant for
linical Data, Inc., which provides the commercially available clinical genetic test for
QTS called Familion. No support was provided for the conduct of this study.
r. Ackerman’s research program is supported by the Dr. Scholl Foundation, the CJ
oundation for SIDS, a Clinical Scientist Development Award from the Doris Duke
haritable Foundation, an Established Investigator Award from the American Heart
ssociation, and the National Institutes of Health (HD42569).c
Manuscript received March 8, 2006; revised manuscript received April 12, 2006,
ccepted May 1, 2006.asis of sudden unexplained death (SUD), such as asthma,
pilepsy, or pulmonary embolism. However, structural car-
iovascular abnormalities identifiable at autopsy including
ypertrophic cardiomyopathy, arrhythmogenic right ven-
ricular cardiomyopathy, congenital coronary artery anom-
See page 247
lies, and myocarditis account for the majority of autopsy-
ositive sudden deaths (1). However, for at least 10% and
erhaps as many as 30% of sudden deaths involving previ-
usly healthy children, adolescents, and young adults, no
bnormalities are evident at autopsy (2). These autopsy-
egative deaths are referred to as SUD syndrome after the
rst year of life (2–4).
Potentially lethal channelopathies, such as catecholamin-
rgic polymorphic ventricular tachycardia (CPVT) and long
T syndrome (LQTS), leave no evidence to be found
uring a comprehensive medicolegal autopsy, leaving coro-
ers, medical examiners, and forensic pathologists only to
onjecture that a fatal arrhythmia might be responsible for
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January 16, 2007:240–6 Molecular Autopsy in Sudden Unexplained Deathhe SUD (5–7). However, a postmortem genetic analysis
i.e., molecular autopsy) may potentially substantiate the
athogenic basis for a SUD (8–12). Previously, we discov-
red pathogenic mutations involving the CPVT1-associated
ardiac ryanodine receptor (RyR2) in 7 of 49 (14%) cases of
UD (13). Recent reports have implicated mutations in the
QTS-associated genes KCNQ1 and KCNH2 in small
ohorts of SUD (8,10,12,14). Our previous population-
ased molecular autopsy of sudden infant death syndrome
SIDS) implicated LQTS-causing channel mutations in
pproximately 5% of infants (11,15). In addition, Crotti et
l. (16) recently reported putative LQTS-associated muta-
ions in 8.3% of SIDS patients derived from a cohort
omprising approximately 200 infants. Although LQTS
enetic testing is a clinically available diagnostic test, post-
ortem mutational analysis, or molecular autopsy, is per-
ormed only in specialized research laboratories at the
resent time.
Congenital LQTS comprises a distinct group of cardiac
hannelopathies characterized by delayed repolarization of
he myocardium, QT prolongation, and increased risk for
yncope, seizures, and sudden cardiac death in the setting of
structurally normal heart. Aborted cardiac arrest or sudden
eath is the sentinel event in 5% to 10% of LQTS cases
17). Approximately 75% of LQTS is caused by mutations
n 5 cardiac channel-encoding genes: KCNQ1 (LQT1),
CNH2 (LQT2), SCN5A (LQT3), KCNE1 (LQT5), and
CNE2 (LQT6), whereas mutations in ANK2-encoded
nkyrin B (LQT4) account for the extremely rare, nonchan-
el subtype of LQTS (18). Mutations in the KCNJ2-
ncoded Kir2.1 potassium channel are responsible for
ndersen-Tawil syndrome (ATS1, formerly called LQT7),
hereas a mutation in the CACNA1C-encoded L-type
alcium channel mediates Timothy syndrome (TS1, for-
erly called LQT8) (19–21).
As such, LQTS may represent an arrhythmogenic disor-
er able to escape suspicion, detection, and apprehension by
ither a standard medicolegal autopsy or a careful evaluation
f those surviving first-degree and second-degree relatives
eft behind (22,23). Here, in our cohort of 49 medical
xaminer/coroner-referred cases of SUD, we now focus on
hese LQTS susceptibility genes as candidate genes respon-
ible for SUD.
ethods
edical examiner/coroner-referred cases of SUD. From
eptember 1998 to March 2004, 49 medical examiner/
oroner cases of SUD from 42 medical examiner offices were
eferred to Mayo Clinic’s Sudden Death Genomics Labo-
atory for a cardiac channel molecular autopsy. By defini-
ion, to be accepted as a case of SUD, the decedent had to
e1 year old and the death had to be sudden, unexpected,
nd unexplained after the conclusion of a comprehensive
edicolegal autopsy. Decedents with a premortem diagno- sis of a cardiac channelopathy
ither in self or in a family mem-
er were excluded from this
tudy.
This study was approved by
he Mayo Foundation Institu-
ional Review Board. Although
nformed consent is waived for
nvestigations involving dece-
ents, written informed consent
rom the decedent’s parents or
ppropriate next-of-kin was ob-
ained.
ostmortem genetic analysis of
he LQTS susceptibility car-
iac channel genes. DNA was extracted from autopsy
lood using standard phenol-chloroform procedures or from
rozen tissue using the Qiagen DNeasy Tissue Kit (Qiagen,
nc., Valencia, California). Using previously published poly-
erase chain reaction primers, comprehensive postmortem
QTS genetic testing, using polymerase chain reaction,
enaturing high-performance liquid chromatography
WAVE, Transgenomic Inc., San Jose, California) and
irect DNA sequencing, was conducted for the entire
oding region (61 translated exons) of the LQTS suscepti-
ility genes: KCNQ1, KCNH2, SCN5A, KCNE1, KCNE2,
nd KCNJ2, as previously described (8,11,24,25).
In addition, a targeted analysis of 10 ANK2 exons
mplicated in LQT4 and a mutation-specific analysis for
S1 (LQT8) involving CACNA1C were also conducted
23). Primers, polymerase chain reaction, and denaturing
igh-performance liquid chromatography conditions for
utation analysis are available on request. Previously, we
erformed a targeted mutational analysis of the CPVT-
ssociated genes: RyR2-encoded ryanodine receptor/
alcium release channel and CASQ2-encoded calseques-
rin, in this cohort of SUD cases (13). In the current
tudy, complete LQTS mutational analysis was per-
ormed for all 49 SUD referral cases in Mayo Clinic’s
udden Death Genomics Laboratory regardless of their
yR2 mutation status.
esults
able 1 summarizes the demographics and clinical pheno-
ype of the 49 SUD cases that were referred by 42 medical
xaminers/coroner offices throughout North America to
ayo Clinic’s Sudden Death Genomics Laboratory for
ostmortem genetic testing during this 6-year study period.
he mean age at death for this mostly white (92%) cohort
f SUD cases was 14.2  10.9 years (mean  SD; range 1
o 43 years). A family history of sudden cardiac death
SCD) or syncope was explicitly documented by the medical
xaminer in 26 cases (13 positive and 13 negative) but was
ot specified in 23 cases. A personal history of syncope,
Abbreviations
and Acronyms
CPVT  catecholaminergic
polymorphic ventricular
tachycardia
ECG  electrocardiogram
LQTS  long QT syndrome
SCD  sudden cardiac
death
SIDS  sudden infant
death syndrome
SUD  sudden unexplained
deatheizure-like activity, or cardiac arrest before the SUD was
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Molecular Autopsy in Sudden Unexplained Death January 16, 2007:240–6eported in 7 cases. Importantly, however, no decedent or
elative had received a clinical diagnosis before death of a
uspected cardiac channelopathy or heritable arrhythmia
yndrome. When specified, most of the deaths occurred
uring sleep (17) or with exertion (12). Among the 19
emale cases of SUD, 2 died suddenly during the postpar-
um period.
linical Characteristics of SUD Cohort
Table 1 Clinical Characteristics of SUD Cohort
All Cases
Individuals, n 49
Gender, n
Male 31
Female 18
Age at SCD
Mean  SD, yrs (range) 14.2 10.9 (1–43)
Reported ethnicity, n
White 41
Black 4
Hispanic 1
Unknown 3
Events at SUD, n (%)
Exertion 12 (24)
Emotion 1 (2)
Sleep 17 (33)
Auditory 1 (2)
Unknown 18 (37)
Personal history prior to SUD, n (%)
Positive 7 (14)
Negative 21 (43)
Unknown 21 (43)
Family history for cardiac events, n (%)
Positive 13 (26.5)
Negative 13 (26.5)
Unknown 23 (47)
CD  sudden cardiac death; SUD  sudden unexplained death.
ummary of LQTS-Associated Mutation/Polymorphism–Positive Cas
Table 2 Summary of LQTS-Associated Mutation/Polymorphism–
Case Gender
Age at
SUD (yrs)
Ethnic
Class Gene Exon Nucleot
1 M 17 W KCNQ1 3 c.Del 572
TGCGC
2 F 43 W KCNQ1 6 c.805 G 
3 M 22 W KCNQ1 6 c.905 C 
4 F 17 W KCNQ1 9 c.1135 T
5 F 5 W KCNQ1 15 c.1750 G
6 F 30 W KCNH2 4 c.526 C 
7 F 15 W KCNH2 7 c.INS GC
8 F 13 W KCNH2 9 c.2398 
9 F 2 B SCN5A
KCNQ1
18
1
c.3308 C
c. DUP 15
GCGCCCA
10 F 16 W SCN5A 28 c.5302 A
11 M 5 W RyR2
KCNQ1
KCNE1
44
16
4
c.6737 C
c.1927 G
c.253 G Denotes a novel mutation. †Denotes a polymorphism.
B  black; Del  deletion; DUP  duplication; F  female; M  male; N/A  not available; NEG  nePostmortem genetic testing for LQTS susceptibility
utations showed 10 putative SUD-associated channel
utations/polymorphisms (4 novel) in 10 cases (20%)
Table 2, Fig. 1). Eight of the 10 mutations were true
QTS susceptibility mutations: LQT1 (5), LQT2 (2), and
QT3 (1), affecting highly conserved residues with noncon-
ervative amino acid substitutions and absent in over 3,000
Positive Cases RyR2-Positive Cases Negative Cases
10 7 32
2 6 23
8 1 9
 11.8 (2–43) 13.6 11.2 (2–34) 12.6 10.6 (1–43)
9 5 27
1 1 2
0 0 1
0 1 2
2 (20) 3 (43) 7 (22)
0 1 (14) 0
5 (50) 0 12 (37)
1 (10) 0 0
2 (20) 3 (43) 13 (41)
3 (30) 1 (14) 3 (1)
7 (70) 6 (86) 8 (3)
0 0 21 (66)
5 (50) 3 (43) 5 (16)
4 (40) 4 (57) 5 (16)
1 (10) 0 22 (69)
tive Cases
ange
Amino Acid
Change Event at SUD
Sentinel
Event
Family
History
p.L191 fs/90 Sleep SUD POS
p.G269S Shoveling snow SUD POS
p.A302V Sleep Seizures NEG
p.W379R* Undetermined SUD POS
p.G584S* Playing in sandbox Syncope POS
p.R176W† 4 months postpartum Syncope NEG
1747 p.R582fs/11* Sleep SUD NEG
T p.L799/sp* Auditory SUD NEG
2
p.S1103Y†
p.API52-54DUP†
Sleep SUD N/A
p.I1768V Sleep SUD POS
p.S2246L
p.G643S†
p.D85N†
Exertion SUD NEGLQTS-
18.0es
Posi
ide Ch
–576
A
T
 C
 A
T
1746–
5 G 
 A
4–16
TC
 G
 T
 A
Agative; POS  positive; SUD  sudden unexplained death; W  white.
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January 16, 2007:240–6 Molecular Autopsy in Sudden Unexplained Deatheference alleles (Fig. 1). In addition 2 mutations, R176W-
CNH2 and S1103Y-SCN5A, are functional polymor-
hisms that confer increased arrhythmia susceptibility to a
ulnerable host (26–28). No pathogenic mutations in the
enes associated with LQT4-6, ATS1, or TS1 were seen.
In conjunction with S1103Y-SCN5A, case 9 was also
hown to harbor the uncommon, relatively black-specific
CNQ1 duplication of amino acids 52-54 (API, Table 2)
29). We speculate that the combination of this duplication
nd the S1103Y-SCN5A functional polymorphism may
ave conferred susceptibility for a fatal arrhythmia. In
ddition to cases 1 to 10, case 11 hosted an established
PVT1-associated mutation (S2246L-RyR2) as well as 2
onsynonymous polymorphisms in LQTS-associated genes:
643S-KCNQ1 and D85N-KCNE1, which is seen in 1%
o 2% of the population (Table 2). No RyR2 variants were
een in the 10 decedents with primary LQTS susceptibility
utations (cases 1 to 10).
Clinically, 8 of the 10 decedents were female and the
verage age at death was 18.0  11.8 years. Overall, 8 of 18
emale subjects (44%) compared with only 2 of 30 male
ubjects (6.7%) hosted LQTS-associated mutations (p 
Figure 1 Summary of LQTS-Associated Channel Mutations in SU
The putative sudden unexplained death (SUD)–associated pathogenic mutations (y
this schematic representation of the linear topology (not drawn to scale) of the ca
the circles correspond to the case numbers in Table 2. Note that the locations of
polymorphism..008). The events at SUD included sleep (5 cases; LQT1 c2], LQT2 [1], LQT3 [2]) exertion (2 cases with LQT1),
uditory trigger (1 case with LQT2), and undetermined (2
ases; LQT1 [1], LQT2 [1]) (Table 2). In contrast to the
nown link between exertional triggers and LQT1, 2 of the
LQT1-associated SUD cases had their sudden death
uring sleep. Consistent with the link between LQT2 and
he postpartum period (8,11,24), one decedent experienced
er SUD 4 months postpartum and was found at molecular
utopsy to host the R176W-KCNH2 functional polymor-
hism.
Personal and family history data were available for 9 of
he 10 cases of SUD hosting a LQTS susceptibility mutation/
olymorphism. Sudden death was the sentinel event in 6 of
he 9 cases (67%), whereas 3 cases (33%) had a personal
istory of either syncope or seizures (Table 2). Five of 9
56%) had a family history positive for cardiac events.
irst-degree and second-degree relatives for 7 of the LQTS
enotype–positive decedents have had confirmatory genetic
esting. The identified mutations were familial in all 7 cases,
nd a total of 23 genotype-positive family members have
een identified so far. Although incomplete penetrance and
ariable expressivity is the norm, each relative tested who
circles) identified in this study are depicted with their approximate location on
hannel subunits implicated in long QT syndrome (LQTS). Numbers shown within
NQ1 and KCNE1 polymorphisms are not shown for case 11. *FunctionalD
ellow
rdiac c
the KContributed the positive family history of cardiac events
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Molecular Autopsy in Sudden Unexplained Death January 16, 2007:240–6osted the LQTS-associated mutation, thus confirming
roper co-segregation.
Figure 2 summarizes the overall yield of the postmortem
enetic analysis, including the previous targeted analysis of
he RyR2-encoded cardiac ryanodine receptor/calcium re-
ease channel that confers susceptibility for CPVT1. Over-
ll, 17 of 49 decedents (35%) hosted a cardiac channel
utation, including 9 of 18 female subjects (50%) and 8 of
0 male subjects (27%). There was a significant cardiac
hannelopathy-gender effect, with 80% of the LQTS-
ssociated mutations detected in females, whereas 6 of 7
86%) CPVT1-associated mutations occurred in male de-
edents (p  0.001). Consistent with the slightly later
anifestation observed in LQTS compared with CPVT
linically, the decedents hosting LQTS-associated muta-
ions tended to be older (18.0 11.8 years) than those with
PVT1-associated mutations (13.6  11.2 years), but this
ailed to achieve statistical significance secondary to the
mall sample size.
iscussion
ere, in this large molecular autopsy series of medical
xaminer/coroner-referred cases of autopsy-negative SUD,
e provide molecular evidence implicating a cardiac chan-
elopathy as the pathogenic basis for 35% of SUD cases,
ncluding 15% with CPVT1 and now 20% with LQTS
usceptibility mutations. In addition, consistent with the
nown natural history of both CPVT and LQTS, there was
striking gender predilection for the elucidated chan-
elopathies, with CPVT1-associated mutations found pre-
ominantly among male decedents, whereas LQTS-
ssociated mutations predominantly involved female
ecedents (30,31).
Certainly, this study is not a population-based study of
UD. The reasons prompting the request for postmortem
utational analysis for these SUD cases from the 42
Figure 2 Summary of the Yield of Postmortem Cardiac Channel
Genetic Testing in Cases of Autopsy-Negative SUD
Depicted is a pie chart summarizing the frequency and distribution of cardiac
channel genotypes detected after a molecular autopsy of 49 medical examiner/
coroner-referred cases of sudden unexplained death (SUD).edical examiner offices represented herein and not others ss unknown. The total number of autopsies performed or
utopsies labeled as SUD by the 42 medical examiner offices
ver this study period is unknown. Nevertheless, the point
stimate of 35% is remarkably congruent with both
opulation-based epidemiology studies of SCD and clinical
tudies involving surviving family members of a sudden
eath victim (2,22,32,33).
In one of the most comprehensive epidemiologic studies
f sudden death in the young to date, Puranik et al. (2)
xamined the autopsy reports from 427 young victims of
nexpected death over a 10-year period in eastern Sydney,
ustralia. More than one-half were determined to be
ardiac in origin, with autopsy-negative SCD and a pre-
umed primary arrhythmia (29%) leading the way. Further,
25-year review of autopsies in military recruits showed a
ontraumatic sudden death rate of 13 per 100,000 recruit
ears with more than one-third (35%) of the sudden deaths
epresenting autopsy-negative SUD (32). In retrospect,
everal cases were identified as having a family history of
udden premature death, suggesting a heritable predisposi-
ion to a malignant cardiac arrhythmia (32).
In 2003, Behr et al. (22) performed a cardiologic
ssessment of first-degree relatives for 32 cases of sudden
rrhythmic death syndrome and showed that 22% of
hese families had evidence of inherited cardiac disease,
ith the majority having clinical features suggestive of
QTS. Similarly, in 2005, Tan et al. (33) found that 28%
f families had an identifiable cardiac channelopathy after
clinical assessment of first-degree relatives of young
UD victims. Together, these reports indicate that iden-
ifiable and treatable cardiac channelopathies account for
pproximately one-third of autopsy-negative sudden
eaths in the young.
In addition, our data suggest that many cases of
utopsy-negative SUD may be preventable. Although
udden death was the sentinel event in the majority of
utation positive cases, many had a positive family
istory of cardiac events, yet no family members carried
he diagnosis of LQTS. Further, 3 decedents had a
ersonal history of syncope or seizure, but no premortem
iagnosis was established. Overall, approximately half of
he 17 decedents with a cardiac channel mutation de-
ected by postmortem genetic testing showed potential
arning signs, either personally or in the family. It is
ritical that such warning signs be heeded and thoroughly
nvestigated. Given the efficacy of LQTS-related thera-
ies, it is expected that a premortem diagnosis of LQTS
ight have thwarted the sudden death.
Although some of these sudden deaths may have been
revented with astute recognition of possible warning
igns, the SUD was nevertheless the sentinel event for
wo-thirds of the LQTS-associated cases and for nearly
ll of the previously published CPVT1-associated cases
13). Inevitably, these data may renew consideration of a
rimary screening program to identify potentially at-risk
ubjects before such a tragic sentinel event. For CPVT, a
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January 16, 2007:240–6 Molecular Autopsy in Sudden Unexplained Deathniversal screening program is difficult to envision be-
ause the resting electrocardiogram (ECG) is always
ormal and exercise/catecholamine stress testing is re-
uired. On the other hand, individuals with LQTS most
t risk for a lethal arrhythmia typically have manifest QT
rolongation on a resting ECG. Although the practicali-
ies, such as cost and feasibility of an ECG screening
rogram in the young, remain debatable, it unavoidably
ollows that if at a relatively young age an ECG had been
erformed on the 10 decedents hosting LQTS-causing
utations, these individuals might have been diagnosed
ith LQTS, enabling the initiation of probable life-
aving pharmacotherapy or device-related therapy.
Finally, a molecular autopsy can have a profound
nfluence on surviving family members and perhaps
hould be considered in all cases of SUD (34). In
ddition, these data support the recommendation of a
omprehensive cardiologic evaluation for surviving first-
egree relatives (35). However, variable expressivity and
ncomplete penetrance are trademarks in arrhythmia
yndromes such as LQTS and CPVT and should be
xpected in this evaluation (36).
Indeed, we have performed pedigree expansion of over
alf of genotype-positive decedents so far and have found
hat most of the mutations are familial. Only one
pontaneous germline mutation has been identified in
his cohort. Confirmatory genetic testing of family mem-
ers has established genotype-positive status for at least
0 relatives, enabling the initiation of prophylactic ther-
py and other preventative measures, such as avoidance of
edications with an unwanted effect on the QT interval.
s shown here, the elucidation of a channelopathy
usceptibility mutation in a postmortem sample may
rovide molecular confirmation regarding the cause and
anner of death and a prospective life saving clue for the
valuation and management of those left behind.
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